James E Wagner Cultivation Corporation (CE) (JWCAF) 銘柄情報

News - James E. Wagner Cultivation to Present at MjMicro Conference on Wednesday, October 16, 2019
Press Release | 10/14/2019
LOS ANGELES, Calif., Oct. 14, 2019 (GLOBE NEWSWIRE) -- James E. Wagner Cultivation Corporation (JWC) (TSX VENTURE: JWCA, OTCQX: JWCAF), a licensed cannabis cultivator and manufacturer focused on producing clean, consistent cannabis, has been invited to present at the MjMicro Conference being held at the Sofitel Beverly Hills Hotel on October 16.

Nathan Woodward, president and CEO of JWC, is scheduled to present on Wednesday, October 16, 2019 at 3:00 p.m. Pacific time, and will also participate in one-on-one meetings with institutional investors and analysts held throughout the day. He will discuss JWC’s advanced aeroponic technology and recent record harvest.

The presentation will also be webcast live and available for replay here and via the investor relations section of the company’s website at www.jwc.ca.

To schedule a one-on-one meeting with JWC, you may submit your request online via the link provided upon registration. To register for the conference, visit the conference website here. For any questions about the company, contact Jonathan Leuchs of CMA at (949) 432-7758 or submit your request here.

About MjMicro Conference
MjMicro Conference is an invitational forum that unites publicly traded and private cannabis companies led by seasoned executives with next level, high net-worth investors. C-level executives from presenting firms have the opportunity to meet one-on-one with next-level private and institutional investors, with a focus on discussing structured investments and providing insight into growth plans. For more information, visit www.mjmicro.com

About James E. Wagner Cultivation Corporation

JWC’s wholly owned subsidiary is a Licensed Producer under the Cannabis Regulations, formerly the Access to Cannabis for Medical Purposes Regulations (ACMPR), focused on producing clean, consistent cannabis. The company’s proprietary Dual Droplet™ technology and GrowthSTORM™ aeroponic platform allows for unmatched consistency of quality and potency in its products. JWC began as a family-operated collective of patients and growers and has remained dedicated to producing the highest quality and most consistent cannabis for medical and recreational use.

For additional information about JWC, please refer to JWC’s profile on SEDAR (www.sedar.com).

For more information, follow the company on Twitter, LinkedIn or visit www.jwc.ca.

Important Cautions Regarding Forward Looking Statements
This press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended, and such as in section 21E of the Securities Act of 1934, as amended. These forward-looking statements should not be used to make an investment decision. The words 'estimate,' 'possible' and 'seeking' and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.

OptimizeRx Contact
James den Ouden, CFO
Tel (519) 594-0144 x 431
james@jwc.ca

Investor Relations Contact
Jonathan Leuchs, CMA
Tel (949) 432-7758
jwca@cma.team

News - James E. Wagner Cultivation Announces Entering Into of Non-Binding Term Sheet With Trichome Financial Corp. for Loan of $4 Million
Email Print Friendly Share
October 04, 2019 07:00 ET | Source: James E. Wagner Cultivation Corporation
KITCHENER, Ontario, Oct. 04, 2019 (GLOBE NEWSWIRE) -- James E. Wagner Cultivation Corporation (“JWC” or the “Corporation”) (TSXV: JWCA), is pleased to announce that on October 3, 2019, JWC entered into a non-binding, indicative term sheet with Trichome Financial Corp. (“Trichome Financial”), summarizing the principal terms and conditions of a proposed loan of $4,000,000 to be advanced by Trichome Financial to JWC in two tranches (the “Term Sheet”).

Pursuant to the Term Sheet, the first tranche, in the amount of $2,850,000 (the “First Tranche Advance”), shall be advanced by Trichome Financial to JWC upon the execution of a definitive agreement between the parties (the “Definitive Agreement”), scheduled to take place on or before October 18, 2019 (such date or such other date as agreed by the parties, the “Closing Date”). The second tranche, in the amount of $1,150,000, shall be advanced by Trichome Financial to JWC upon satisfaction of certain conditions precedent in favour of Trichome Financial (the “Second Tranche Advance”, and together with the First Tranche Advance, the “Loan”).

The term of the Loan shall be for two years calculated from the Closing Date, and shall be payable in full upon maturity. Interest on the Loan shall be paid monthly in cash at a rate of 9.25% per annum on the then outstanding amount of the Loan, with all outstanding interest payable upon maturity. JWC shall use the net proceeds of the Loan to finance construction and capital expenditures related to phases 2C and 3 of its facility located at 530 Manitou Drive in Kitchener, Ontario and for general working capital requirements (the “Use of Proceeds”). The Use of Proceeds shall be further defined in the Definitive Agreement. As security for the Loan, JWC shall provide Trichome Financial with a perfected, first lien on current and future tangible and intangible assets ?and equity interests (including a share pledge from all active ?subsidiaries) of JWC and each of the direct and indirect wholly owned subsidiaries organized ?under JWC. In the event JWC, for whatever reason, cannot or elects not to close the First Tranche Advance portion of the Loan on or before the Closing Date, or any mutual extension thereof, JWC shall pay Trichome Financial a cash fee in the amount equal to 10% of the number of Bonus Warrants that would have been issued as Additional Consideration multiplied by the Exercise Price, subject to the option of being settled in warrants of JWC in accordance with TSX Venture Exchange (“TSXV”) Policy 4.3 – Shares for Debt, should the need arise.

?For greater certainty, the Loan shall be in ?addition to the $3,500,000 term loan previously advanced by Trichome Financial to JWC, pursuant to the previously disclosed loan agreement dated ?February 19, 2019.?

As additional consideration for providing the Loan (the “Additional Consideration”) and pursuant to TSXV Policy 5.1 – Loans, Loan Bonuses, Finder’s Fees and Commissions, JWC intends issue to Trichome Financial warrants to purchase common shares of JWC (the “Bonus Warrants”) in an amount equal to ?50% of the Loan divided by the lower of a 5% premium to: (i) the ?price per share of JWCA.V on October 3, 2019; and (ii) the price per share of JWCA.V on the last trading day immediately preceding the Closing Date, which lower amount shall be the exercise price at which each Bonus Warrant shall be exercisable into common shares of JWC (the “Exercise Price”). Based on the closing price of JWCA.V on October 3, 2019, the Exercise Price would be $0.5565, and the amount of Bonus Warrants given as the Additional Consideration with respect to the Loan would be 3,593,890 Bonus Warrants. Such amount is below the maximum number of warrants that may be granted pursuant to Section 2.2(b) of TSXV Policy 5.1 with respect to the First Tranche Advance which, as of market close on October 3, 2019, is 5,027,830 warrants. ?The Bonus Warrants will be exercisable for a period of two years from the date of issuance, which shall be the Closing Date. ?

About James E. Wagner Cultivation Corporation

JWC’s wholly owned subsidiary is a Licensed Producer under the Cannabis Regulations, formerly the Access to Cannabis for Medical Purposes Regulations (“ACMPR”). JWC is a premium cannabis brand, focusing on producing clean, consistent cannabis. JWC uses an advanced and proprietary Dual Droplet aeroponic platform named GrowthSTORM™. JWC was founded as a family company and is based on family values. JWC began as a collective of patients and growers under the Marihuana Medical Access Regulations (the precursor to ACMPR). Since its inception, JWC has remained focused on providing the best possible patient experience. JWC’s operations are based in Kitchener, Ontario. Learn more at www.jwc.ca.

For additional information about JWC, please refer to JWC’s profile on SEDAR (www.sedar.com) or the Corporation’s website: www.jwc.ca.

Yo Where’s Every1 At?

This thing is like an artery exploding. Been going down for 2 months now. Got in this pos on a recommendation. Will never use that company's advice again. Total loser, never any positive push. Almost time to clear out of this loser. James is a loser sorry to say lol. Garbage stock, STAY AWAY.

received cultivation licence on 3/29/2019 and today up 15%...not at all

bad for them...maybe bring some life to this bd...better things ahead...

CharlieB

Could see over $1 today

https://midasletter.com/2018/10/james-e-wagner-cultivation-corp-predicts-organic-certification-is-coming/

James West's Midas Letter - Oct 17th @11:30 JWCAF CEO Nathan Woodworth will be stopping by the studio at 11:30am ET.
Interested parties can Watch Live on MidasLetter.com

Company Website: https://www.jwcmed.com/home.html

James E. Wagner Cultivation, a Canopy Rivers' portfolio best-in-class company.

https://www.canopyrivers.com